Author: Andrew Powrie-Smith Date: 05/04/2016 Version: draft

Value to the Economy

The biopharmaceutical industry makes a significant contribution to the European economy

The biopharmaceutical industry makes a significant contribution to the European economy

The Biopharmaceutical Sector is the Second largest funder of R&D in Europe

The Biopharmaceutical Sector is the Second largest funder of R&D in Europe

The biopharmaceutical sector accounts for the second largest share of all business R&D, representing 19% of all domestic R&D funded by EU businesses.

Automobiles & Parts

Pharmaceuticals & Biotechnology

Technology Hardware

Aerospace & Defense

Electronic & Electrical Equipment

Industrial Engineering

Software & Computer Services

Share of European Business R&D by Industry, 2014*
* The remaining 26% share of business R&D spending is conducted by other industries including chemical sector, the general industrial sector, and the professional, scientific, and technical services sector, among others.
Source:: Health Advances analysis; European Commission 2015 EU Industrial R&D Investment Scoreboard.

The pharmaceutical industry invests more of its revenue in generating new knowledge through research and development than other sectors

The pharmaceutical industry invests more of its revenue in generating new knowledge through research and development than other sectors

* Industrial sectors ranked by R&D intensity (R&D as a percentage of net sales) Note: data relate to the top 2,500 companies with registered offices in the EU (633), Japan (387), the USA (804) and the Rest of the World (676), ranked by total worldwide R&D investment (with R&D investment above €15.5M)Source: The 2014 EU industrial R&D investment scoreboard, European Commission, JRC, DG RTD.
14.4%: Pharmaceuticals and biotechnology
10.4%: Software and computer services
8%: Technology hardware and equipment
7.3%: Leisure goods
4.2%: Healthcare equipment and services
2.6%: Chemicals
R&D spending as a percentage of net sales, 2014